| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5K | -28.6% |
| R&D Expense | $6.0M | -37.8% |
| SG&A Expense | $14.4M | -33.9% |
| Operating Income | -$20.4M | +35.1% |
| Pre-tax Income | -$18.2M | +35.0% |
| Income Tax | $3K | +103.8% |
| Net Income | -$18.2M | +34.8% |
| EPS (Basic) | -$5.05 | +35.2% |
| EPS (Diluted) | -$5.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.3M | -11.4% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $38.2M | -29.0% |
| Total Assets | $49.6M | -17.9% |
| Current Liabilities | $7.2M | +473.8% |
| Total Liabilities | $10.0M | +127.0% |
| Stockholders' Equity | $39.6M | -29.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | +38.1% |
| Capital Expenditures | $22K | -66.2% |
| Investing Cash Flow | $12.5M | -65.3% |
| Financing Cash Flow | -$129K | +99.8% |
| Free Cash Flow | -$15.3M | +38.2% |
| +35.2% |